MoneyWorks4Me

Zim Laboratories - Quaterly Results

12 Nov 2022 Evaluate
The sales figure stood at Rs. 992.64 millions for the September 2022 quarter. The mentioned figure indicates a growth of about 31.08% as compared to Rs. 757.26 millions during the year-ago period.Net Profit witnessed a 182.52% growth almost the double from Rs. 20.02 millions to Rs. 56.56  millions  of same quarter last year.Operating Profit saw a handsome growth to 135.59 millions from 95.71 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 992.64 757.26 31.08 1917.67 1393.66 37.60 3294.94 3036.29 8.52
Other Income 14.38 8.87 62.12 33.11 21.38 54.86 45.06 24.49 83.99
PBIDT 135.59 95.71 41.67 268.11 157.51 70.22 424.40 392.62 8.09
Interest 13.58 25.79 -47.34 26.89 51.25 -47.53 83.06 108.86 -23.70
PBDT 122.01 69.92 74.50 241.22 106.26 127.01 341.34 231.95 47.16
Depreciation 40.43 40.65 -0.54 79.94 74.29 7.61 148.37 146.14 1.53
PBT 81.58 29.27 178.72 161.28 31.97 404.47 192.97 85.81 124.88
TAX 25.02 9.25 170.49 48.30 10.09 378.69 62.84 29.64 112.01
Deferred Tax 10.11 4.61 119.31 20.06 5.24 282.82 28.84 29.47 -2.14
PAT 56.56 20.02 182.52 112.98 21.88 416.36 130.13 56.17 131.67
Equity 162.42 162.42 0.00 162.42 162.42 0.00 162.42 162.42 0.00
PBIDTM(%) 13.66 12.64 8.07 13.98 11.30 23.70 12.88 12.93 -0.39
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..